GlaxoSmithKline to develop HGS drug - 2005-07-07
HGSI is in an interesting situation. The company is losing money because it has many clinical trials in progress. Companies that are willing to take the hit in the short run can be real winners in the long run. I do not own the stock but several of my readers are big holders of GSK. When bond rates start rising, drug stocks will likely do better than the average stock. A situation worthy of study.
STOCKS ARE CHEAP! BUY THE BULL!
Saturday, July 09, 2005
GlaxoSmithKline to develop HGS drug - 2005-07-07
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment